Related Experiment Video
Updated: Feb 14, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Initiative action of tumor-associated macrophage during tumor metastasis
Saroj Singh1, Neesha Mehta1, Jiang Lilan1
1Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Chongqing Medical University, No. 426 Songshibei Road, Yubei District, Chongqing 401147, China.
Abstract:
Tumor-associated macrophages (TAMs) are a significant component of the microenvironment of any solid tumors in the majority of cancers, associated with unfavorable prognosis. TAMs emerge as attractive targets for therapeutic strategies aimed at reprogramming their protumor phenotype into an effective antitumor activity. In this review article, we present an overview of mechanisms responsible for TAMs recruitment and highlight the roles of TAMs in the regulation of tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapeutic resistance. We describe the interplay between Th17 cells and other immune cells in the tumor microenvironment, and we assess both the potential antitumorigenic and pro-tumorigenic activities of Th17 cells and their associated cytokines. Understanding the nature of Th17 cell responses in the tumor microenvironment will be important for the design of more efficacious cancer immunotherapies. Finally, we discuss TAM-targeting therapy as a promising novel strategy for an indirect cancer therapy.
Insights
Tumor-associated macrophages (TAMs) are key players in cancer progression and therapeutic resistance. Targeting TAMs offers a promising strategy for developing novel cancer immunotherapies.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumor-associated macrophages (TAMs) are prevalent in solid tumors, correlating with poor patient outcomes.
- TAMs can be reprogrammed from a pro-tumor to an anti-tumor phenotype, presenting a therapeutic opportunity.
Purpose of the Study:
- To review TAM recruitment mechanisms and their roles in tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapy resistance.
- To explore the dual role of Th17 cells and their cytokines within the tumor microenvironment.
- To discuss TAM-targeting therapies as a novel cancer treatment strategy.
Main Methods:
- Literature review of mechanisms of TAM recruitment and function.
- Analysis of the interplay between Th17 cells and other immune cells.
- Assessment of TAM-targeting therapeutic strategies.
Main Results:
- TAMs significantly influence tumor progression through angiogenesis, invasion, metastasis, and immune evasion.
- Th17 cells exhibit both pro-tumorigenic and anti-tumorigenic activities in the tumor microenvironment.
- Targeting TAMs represents a viable approach for indirect cancer therapy.
Conclusions:
- Understanding TAMs and Th17 cell dynamics is crucial for advancing cancer immunotherapy.
- Reprogramming TAMs holds potential for enhancing anti-tumor immunity and overcoming therapeutic resistance.
Related Concept Videos
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

